Printer Friendly

HIV and the BBB.

HIV can cause damage to the brain, including problems in thinking and understanding information. This damage is thought to occur because certain HIV drugs cannot get into the brain to suppress the HIV infection. The blood-brain barrier (BBB)is a tightly connected network of cells that surrounds the brain and protects it from outside substances. However, the BBB also prevents many beneficial drugs from entering the brain. At the conference, 2 studies questioned whether using HIV medications that are able to get through the BBB actually protect against damage caused by HIV. In the first study (abstract 501), the cognitive ability of 32 HIV+ patients taking one of the medications believed to penetrate the BBB was compared to that of 14 HIV+ patients not taking one of these drugs. A second study (abstract 508) examined 165 HIV+ patients and compared cognitive ability in those patients taking an HIV medication thought to penetrate the BBB to those patients who were not. Both studies found that a higher viral load was associated with cognitive problems, rather than the specific HIV medications. In the second study, higher levels of education were shown to protect patients against these types of problems. In terms of protecting the brain and the body from HIV, the most important factor is keeping viral load low. Patients should be sure to have their viral load measured every 3 to 4 months and take HIV medications regularly and on-time.
COPYRIGHT 2004 The Center for AIDS: Hope & Remembrance Project
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:11th Retrovirus Conference Highlights; blood-brain barrier
Publication:HIV Treatment: ALERTS!
Article Type:Brief Article
Geographic Code:1USA
Date:Jun 1, 2004
Previous Article:Managing lipids.
Next Article:It's all about attitude.

Related Articles
HIV-2 case found, AIDS drug tested.
Study shows AIDS virus may be hiding out.
AIDS: envelope research update.
HIV: more tricks up its sleeve.
Fetal AIDS mimicked in brain-cell culture.
HIV-fighting protein in human saliva.
AIDS optimism high despite therapy cost.
HIV: hiding in plain sight.
Conference highlights.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters